key: cord-0863938-9np83832
authors: nan
title: 肿瘤合并新型冠状病毒感染的临床特征与应对策略
date: 2020-04-20
journal: Zhongguo Fei Ai Za Zhi
DOI: 10.3779/j.issn.1009-3419.2020.102.15
sha: b1f8aa13029ba3025f27543dd4a18d70f646266f
doc_id: 863938
cord_uid: 9np83832

Since mid-December 2019, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has outbroken in Wuhan, Hubei Province, China, and spread rapidly to other provinces in China and dozens of countries and regions around the world, becoming the Public Health Emergency of International Concern (Public Health Emergency of International Concern). SARS-CoV-2 can mainly transmit by droplets or close contact, and is generally susceptible in the crowd. Tumor patients are at high risk of this pathogen because of their impaired immune function. Identifying tumor patients with 2019 novel coronavirus disease (COVID-19) early, and understanding its distribution characteristics can help to improve the cure rate of patients, and better control the epidemic and development of SARS-CoV-2 much better. With comprehensive analysis of relevant literature, this paper reviews the clinical characteristics of neoplastic patients with COVID-19, and puts forward some suggestions on how to deal with this epidemic.

，其死因主要是多器官功能障碍，其次为 ARDS [19] ， 这可能与ACE2在多种器官中广泛分布有关 [20, 21] 

MERS-CoV spike protein: Targets for vaccines and therapeutics

HIV-1 did not contribute to the 2019-nCoV genome

Epidemiological, demographic, and clinical characteristics of 47 cases of Middle East respirator y sy ndrome coronav ir us disease from Saudi A rabia: a descriptive study

Plasma inflammatory cytokines and chemokines in severe acute respiratory syndrome

SARS and MERS: recent insights into emerging coronaviruses

A novel coronavirus outbreak of global health concern

A pneumonia outbreak associated with a new coronavirus of probable bat origin

Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis

Cancer patients in SA RS-CoV-2 infection: a nationwide analysis in China

The Novel Coronavirus Pneumonia Emergency Response Epidemiology Team. The epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases (COVID-19) in China

Emerg ing 2019 novel coronav ir us (2019-nCoV) pneumonia

The differential diagnosis of pulmonary infiltrates in cancer patients during the outbreak of the 2019 novel coronavirus disease

Pulmonary pathology of early-phase 2019 novel coronavirus (COV ID-19) pneumonia in two patients with lung cancer

Consistent detection of 2019 novel coronavirus in saliva

MERS-CoV infection in humans is associated with a pro-inflammatory Th1 and Th17 cytokine profile

Clinical Characteristics and Coping Strategies of Neoplasms with 2019 Novel Coronavirus Infection